Franklin Resources’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Franklin Resources's IBRX Position: Q2 2026 in Review
Franklin Resources increased its ImmunityBio (IBRX) stake by 19% in Q2 2026, buying an estimated $689K and bringing the position to 582,182 shares worth $5.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.
Franklin Resources first reported a position in IBRX in Q3 2015 and has held it in 16 quarters since. The position peaked at $28.8M in Q4 2015. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.
- Franklin Resources held 582,182 shares of ImmunityBio worth $5.1M as of Q2 2026.
- Franklin Resources bought 91,089 ImmunityBio shares in Q2 2026, an estimated $689K.
- ImmunityBio made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1592 holding.
- Franklin Resources first reported a position in ImmunityBio in Q3 2015 and has held it in 16 quarters since.
- Franklin Resources's ImmunityBio position peaked at $28.8M in Q4 2015.
- 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.